中文
| Catalogue |
| Recommend Products |
Company News
- Merck Announces Collaborations and Investment in all Three Business Sectors in China 6/20/2018
- Merck Completes Third and Final Registration Phase 6/7/2018
- Merck Receives Patent for CRISPR Technology in China 4/24/2018
- Merck and Schneider Electric Sign MoU to Advance China’s Biopharmaceutical Industry 3/8/2018
- Merck Strengthens Corporate Responsibility Efforts with Nine New Signature Partnerships 2/26/2018
- Merck Accelerates Mobius® Single-Use Manufacturing in Wuxi 2/24/2018
- Merck was Granted Patent for Application for CRISPR Technology 10/25/2017
- Merck Brings Customers Closer to Gene Therapy Product Commercialization 10/19/2017
- Merck Opens New Life Science Center for Scientific Collaboration 10/12/2017
- Merck Provides Update to Improve Biopharmaceutical Downstream Processing 9/28/2017
- Merck announces new, double filtration capacity,first-of-its Kind Filters 9/27/2017
- Merck Opens China’s First End-to-End Biodevelopment Center in Shanghai 9/22/2017
- Merck today launched Eshmuno® P anti-A and anti-B affinity chromatography resins 9/21/2017
- Merck Expands Celonic’s Upstream Capabilities with Mobius® Single-use Bioreactors 9/14/2017
- Merck Opens its First Customer Food Safety Studio 8/31/2017
- Merck to Acquire Natrix Separations to Advance Next-Generation Processing Capabilities 8/29/2017
- European Patent Office Grants Merck’s Patent Application for CRISPR Technology 8/4/2017
- Merck Refines Western European Life Science Production Site Network 7/13/2017
- Merck announced the establishment of the Merck Foundation 6/23/2017
- Merck Awarded its First CRISPR Patent by Australian Patent Office 6/19/2017